Revance Therapeutics Inc (RVNC)

[floblu14]

From Twitter -

Needham All Daxi doses demonstrated a duration of at least 24 wks. $RVNC remains one of our top-ideas due to Daxi's mostly-derisked vast potential, and the co's M&A appeal. maintain our Buy rating and $45PT.

Cowen: $RVNC STRONG EARLY RHA PERFORMANCE NICELY LAYING THE GROUNDWORK FOR DAXI, Importantly, DAXI continued
to demonstrate differentiated durability up to 24 weeks, which could also – like the aesthetic market – alter the therapeutic treatment paradigm. TP=$55.